首页> 外文OA文献 >A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

【2h】

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

机译：卡铂加聚乙二醇化脂质体多柔比星与卡铂联合紫杉醇治疗铂类敏感性卵巢癌患者的随机II期研究：希腊合作肿瘤学小组研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Briasoulis Evangelos; Samantas Epaminondas; Makatsoris Thomas; Timotheadou Eleni; Kosmidis Paris; Kalofonos Haralabos P; Fountzilas George; Bamias Aristotelis; Papadimitriou Christos; Aravantinos Gerasimos; Linardou Helena; Bafaloukos Dimitrios; Christodoulou Christos; Papakostas Pavlos; Pectasides Dimitrios; Dimopoulos Athanasios M;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study [J] . Dimitrios Bafaloukos, Helena Linardou, Gerasimos Aravantinos, BMC Medicine . 2010,第1期

机译：卡铂+聚乙二醇化脂质体阿霉素与卡铂+紫杉醇在铂敏感型卵巢癌患者中的随机II期研究：希腊合作肿瘤小组研究
2. 5003 ORAL A randomised phase II study of carboplatin plus liposomal doxorubicin (CLD) vs carboplatin plus paclitaxel (CP) in potentially platinum sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group study [J] . H.Linardou, D.Bafaloukos, A.Bamias, European Journal of Cancer Supplements . 2007,第4期

机译：5003口服对潜在铂敏感型卵巢癌患者进行的卡铂加脂质体阿霉素（CLD）与卡铂加紫杉醇（CP）的随机II期研究。希腊合作肿瘤小组研究
3. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial [J] . Mahner Sven, Meier Werner, du Bois Andreas, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第3期

机译：卡铂和聚乙二醇脂质体阿霉素与卡铂和紫杉醇对高度铂敏感的卵巢癌患者的比较：来自CALYPSO III期试验的子集分析结果
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study [O] . Dimitrios Bafaloukos, Helena Linardou, Gerasimos Aravantinos, 2010

机译：卡铂+聚乙二醇化脂质体阿霉素与卡铂+紫杉醇在铂敏感型卵巢癌患者中的II期随机研究：希腊合作肿瘤小组研究
7. A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study [O] . Dimitrios Bafaloukos, Helena Linardou, Gerasimos Aravantinos, 2010

机译：卡铂+聚乙二醇化脂质体阿霉素与卡铂+紫杉醇在铂敏感型卵巢癌患者中的II期随机研究：希腊合作肿瘤小组研究

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

著录项

引文网络

相似文献

相关主题

期刊订阅